Black Rock Inc. Regencell Bioscience Holdings LTD Transaction History

Black Rock Inc.

  • $4.35 Trillion
  • Q2 2024

A detailed history of Black Rock Inc. transactions in Regencell Bioscience Holdings LTD stock. As of the latest transaction made, Black Rock Inc. holds 238 shares of RGC stock, worth $1,447. This represents 0.0% of its overall portfolio holdings.

Number of Shares
238
Previous 238 -0.0%
Holding current value
$1,447
Previous $1,000 100.0%
% of portfolio
0.0%
Previous 0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 12, 2022
BUY
$20.67 - $45.78 $4,919 - $10,895
238 New
238 $8,000

Others Institutions Holding RGC

# of Institutions
4
Shares Held
563
Call Options Held
0
Put Options Held
0
View Full List

About Regencell Bioscience Holdings Ltd

RGC Quotes by TradingView
  • Ticker RGC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 13,012,900
  • Market Cap $79.1M
  • Description
  • Regencell Bioscience Holdings Limited operates a Traditional Chinese medicine (TCM) bioscience company. It focuses on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, primarily attention deficit hyperactivity disorder and autism spectrum disorder. The company was incorporated...
More about RGC
Track This Portfolio

Track Black Rock Inc. Portfolio

Follow Black Rock Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email